By Canadian Press

Montreal network to tackle ‘explosion’ in infections such as syphilis with new trials

Jul 17, 2024 | 12:55 PM

MONTREAL — A Monteal-based HIV/AIDS research network is expanding its scope in response to a dramatic rise in rates of sexually transmitted diseases such as syphilis.

Dr. Marina Klein of the McGill University Health Centre says syphilis rates have increased by more than 100 per cent in recent years across Canada, while HIV diagnoses rose almost 25 per cent between 2021 and 2022.

Klein says the reasons are complex but include COVID-19 disruptions, immigration patterns, barriers to accessing care and changes in the infections themselves.

She says the Pan-Canadian HIV/AIDS Clinical Trials Network will widen its focus to include all sexually transmitted and blood-borne infections and help find new ways to treat them.

Klein, who directs the network, says the group will conduct clinical trials across the country into diseases including mpox — formerly monkeypox — syphilis and hepatitis B.

SOMETHING FOR EVERYONE

Central Alberta Theatre lifts the curtain on 2024-25 season

3h ago

13.3 PER CENT LOSS

Lacombe water audit finds loss rates down for third year running

3h ago

WILL SEEK PUBLIC INPUT

Sylvan Lake town council passes first reading of OHV bylaw

3h ago

She says the network also wants to study prevention and treatment approaches for groups who experience stigma or may not be able to access consistent care, including those living in Indigenous communities.

This report by The Canadian Press was first published July 17, 2024.

The Canadian Press